4//SEC Filing
Persen Kenneth Harry 4
Accession 0001779372-23-000017
CIK 0001779372other
Filed
Jun 8, 8:00 PM ET
Accepted
Jun 9, 7:59 PM ET
Size
6.0 KB
Accession
0001779372-23-000017
Insider Transaction Report
Form 4
HeartBeam, Inc.BEAT
Persen Kenneth Harry
Chief Technology Officer
Transactions
- Award
Stock option (right to buy)
2023-05-14+169,000→ 169,000 totalExp: 2033-05-13→ Common Stock (169,000 underlying)
Footnotes (3)
- [F1]The exercise price per share of each option (?Option? and collectively, the ?Options?) shall be the Fair Market Value (as defined in the Company?s 2022 Equity Incentive Plan) of a share as of May 14, 2023.
- [F2]The Options have been issued from the Company's 2022 Equity Incentive Plan, that was approved by the Members of the Board of Directors on May 14, 2023.
- [F3]The Options will vest and become exercisable with respect to 40% of the shares starting May 14, 2023, with one forty-eighth (1/48th) of the shares vesting each calendar month thereafter on the same day of the month as the first vesting date. The remaining 60% of the shares will vest and become exercisable once HeartBeam, Inc. receives FDA Clearance for marketing of HeartBeam?s synthesized 12-Lead product obtained by signal synthesis from the recorded xyz signals.
Documents
Issuer
HeartBeam, Inc.
CIK 0001779372
Entity typeother
Related Parties
1- filerCIK 0001942350
Filing Metadata
- Form type
- 4
- Filed
- Jun 8, 8:00 PM ET
- Accepted
- Jun 9, 7:59 PM ET
- Size
- 6.0 KB